Used in cancer research, particularly in studies involving leukemia and other solid tumors. It functions as a topoisomerase II inhibitor, which interferes with DNA replication in cancer cells, leading to cell death. Due to this mechanism, it has been investigated in clinical trials for its antitumor activity. Its application is primarily experimental and confined to laboratory and clinical settings, with ongoing evaluation for efficacy and safety in chemotherapy regimens.